INTENSITY THERAPEUTICS, INC. Operating Lease, Expense
INTENSITY THERAPEUTICS, INC. (INTS) reported Operating Lease, Expense of $9.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-08-11
- INTENSITY THERAPEUTICS, INC. operating lease, expense for the quarter ending 2026-06-30 was $9.00K, a 0.00% change year-over-year.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for the quarter ending 2026-03-31 was $9.00K, a 0.00% change year-over-year.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-12-31 was $8.00K, a 0.00% change year-over-year.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for the quarter ending 2025-09-30 was $9.00K, a 0.00% change year-over-year.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for fiscal 2025 was $34.00K, a 0.00% change from fiscal 2024.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for fiscal 2024 was $34.00K, a 38.18% decline from fiscal 2023.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for fiscal 2023 was $55.00K, a 54.17% decline from fiscal 2022.
- INTENSITY THERAPEUTICS, INC. operating lease, expense for fiscal 2022 was $120.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-11 | $17.00K 10-Q · filed 2026-08-11 | $26.00K derived: sum of 3 quarters · filed 2026-08-11 | $35.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-07 | $17.00K derived: sum of 2 quarters · filed 2026-05-07 | $26.00K derived: sum of 3 quarters · filed 2026-05-07 | $35.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $17.00K derived: sum of 2 quarters · filed 2026-03-27 | $26.00K derived: sum of 3 quarters · filed 2026-08-11 | $34.00K 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $9.00K 10-Q · filed 2025-11-06 | $18.00K derived: sum of 2 quarters · filed 2026-08-11 | $26.00K 10-Q · filed 2025-11-06 | $35.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-11 | $17.00K 10-Q · filed 2026-08-11 | $9.00K 10-Q · filed 2025-08-07 | $26.00K derived: sum of 3 quarters · filed 2026-08-11 | $35.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-07 | $17.00K derived: sum of 2 quarters · filed 2026-05-07 | $26.00K derived: sum of 3 quarters · filed 2026-05-07 | $43.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $17.00K derived: sum of 2 quarters · filed 2026-03-27 | $34.00K derived: sum of 3 quarters · filed 2026-03-27 | $34.00K 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $9.00K 10-Q · filed 2025-11-06 | $26.00K derived: sum of 2 quarters · filed 2025-11-06 | $26.00K 10-Q · filed 2025-11-06 | $35.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $17.00K 10-Q · filed 2025-08-07 | $17.00K 10-Q · filed 2025-08-07 | $26.00K derived: sum of 3 quarters · filed 2025-08-07 | $29.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-13 | $9.00K derived: sum of 2 quarters · filed 2025-05-13 | $12.00K derived: sum of 3 quarters · filed 2025-05-13 | $12.00K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $3.00K derived: sum of 2 quarters · filed 2025-03-13 | $3.00K derived: sum of 3 quarters · filed 2025-03-13 | $55.00K 10-K · filed 2025-03-13 | $63.00K 10-K · filed 2024-03-14 | |
| 2023-09-30 | $3.00K 10-Q · filed 2024-11-13 | $3.00K derived: sum of 2 quarters · filed 2024-11-13 | $55.00K 10-Q · filed 2024-11-13 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $46.00K 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $46.00K 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | $120.00K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |